Insmed to Present at Two November Conferences

BRIDGEWATER, N.J., Nov. 5, 2019 /PRNewswire/ -- Insmed Incorporated INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:

  • The Credit Suisse 28th Annual Healthcare Conference in Scottsdale, AZ on Tuesday, November 12, 2019 at 10:20 a.m. MT.
  • The Stifel 2019 Healthcare Conference in New York, NY on Tuesday, November 19, 2019 at 4:10 p.m. ET.

Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the company's website at www.insmed.com. The webcasts will be archived for a period of 90 days following the conclusion of each live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product, ARIKAYCE® (amikacin liposome inhalation suspension), is the first and only therapy approved in the United States for the treatment of refractory Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a chronic, debilitating condition that can cause severe and permanent lung damage. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension. For more information, visit www.insmed.com.

Contact:

Blaine Davis

Head of Investor Relations and Corporate Communications

Insmed Incorporated

(908) 947-2841 

blaine.davis@insmed.com 

(PRNewsfoto/Insmed Incorporated)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-two-november-conferences-300951470.html

SOURCE Insmed Incorporated

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releasestrade shows
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!